相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Multitarget Therapy for Induction Treatment of Lupus Nephritis A Randomized Trial
Zhihong Liu et al.
ANNALS OF INTERNAL MEDICINE (2015)
Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial)
David Isenberg et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Lupus Nephritis: The Evolving Role of Novel Therapeutics
Brad H. Rovin et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
LB0003 A Randomized Controlled Study of Laquinimod in Active Lupus Nephritis Patients in Combination with Standard of Care
D. Jayne et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
Ronald F. van Vollenhoven et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Emerging biological therapies for systemic lupus erythematosus
Chi Chiu Mok
EXPERT OPINION ON EMERGING DRUGS (2014)
Overview of lupus nephritis management guidelines and perspective from Asia
Chi Chiu Mok et al.
NEPHROLOGY (2014)
Urine biomarkers for monitoring juvenile lupus nephritis: a prospective longitudinal study
Louise Watson et al.
PEDIATRIC NEPHROLOGY (2014)
Long-Term Follow-Up of a Phase III Clinical Trial Comparing Tacrolimus Extended-Release/MMF, Tacrolimus/MMF, and Cyclosporine/MMF in De Novo Kidney Transplant Recipients
Helio Tedesco Silva et al.
TRANSPLANTATION (2014)
Efficacy and Safety of Abatacept in Lupus Nephritis A Twelve-Month, Randomized, Double-Blind Study
Richard Furie et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Treatment of Lupus Nephritis With Abatacept
Anca D. Askanase et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids
Marie B. Condon et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Efficacy and Safety of Ocrelizumab in Active Proliferative Lupus Nephritis: Results From a Randomized, Double-Blind, Phase III Study
Eduardo F. Mysler et al.
ARTHRITIS AND RHEUMATISM (2013)
Effect of Renal Disease on the Standardized Mortality Ratio and Life Expectancy of Patients With Systemic Lupus Erythematosus
C. C. Mok et al.
ARTHRITIS AND RHEUMATISM (2013)
Lupus Nephritis: Induction Therapy in Severe Lupus Nephritis-Should MMF Be Considered the Drug of Choice?
Brad H. Rovin et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Lupus Nephritis: Maintenance Therapy for Lupus Nephritis-Do We Now Have a Plan?
Oliver Lenz et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
The applied basic research of systemic lupus erythematosus based on the biological omics
W. Sui et al.
GENES AND IMMUNITY (2013)
Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE
M. A. Dooley et al.
LUPUS (2013)
Lupus nephritis: a 15-year multi-centre experience in the UK
M. Hui et al.
LUPUS (2013)
Combined low-dose mycophenolate mofetil and tacrolimus for lupus nephritis with suboptimal response to standard therapy: a 12-month prospective study
C. C. Mok et al.
LUPUS (2013)
Renoprotective strategies in lupus nephritis: beyond immunosuppression
B. Griffin et al.
LUPUS (2013)
Beyond the LUNAR trial. Efficacy of rituximab in refractory lupus nephritis
Marc Weidenbusch et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Urine biomarkers in juvenile-onset SLE nephritis
Louise Watson et al.
PEDIATRIC NEPHROLOGY (2013)
Multifaceted effects of hydroxychloroquine in human disease
Nancy J. Olsen et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2013)
B-cell depletion in SLE: clinical and trial experience with rituximab and ocrelizumab and implications for study design
Venkat Reddy et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Biomarker Profiling for Lupus Nephritis
Yajuan Li et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2013)
Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis
Suzanne Arends et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response
Ronald F. van Vollenhoven et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials
Susan Manzi et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
George K. Bertsias et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian-European populations
Elena Sanchez et al.
ARTHRITIS AND RHEUMATISM (2012)
Efficacy and Safety of Rituximab in Patients With Active Proliferative Lupus Nephritis The Lupus Nephritis Assessment With Rituximab Study
Brad H. Rovin et al.
ARTHRITIS AND RHEUMATISM (2012)
Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: Pooled data from European cohorts
Candido Diaz-Lagares et al.
AUTOIMMUNITY REVIEWS (2012)
Abatacept for systemic lupus erythematosus: the outlook
Chi Chiu Mok
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
Hydroxychloroquine in lupus: emerging evidence supporting multiple beneficial effects
C. Tang et al.
INTERNAL MEDICINE JOURNAL (2012)
Role of TWEAK in lupus nephritis: A bench-to-bedside review
Jennifer S. Michaelson et al.
JOURNAL OF AUTOIMMUNITY (2012)
Multicenter longitudinal study of B-lymphocyte depletion in refractory systemic lupus erythematosus: the LESIMAB study
A. Fernandez-Nebro et al.
LUPUS (2012)
Outcomes of maintenance therapy with tacrolimus versus azathioprine for active lupus nephritis: a multicenter randomized clinical trial
W. Chen et al.
LUPUS (2012)
Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis
Xiao Li et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Membranous Nephropathy in Systemic Lupus Erythematosus: Long-Term Outcome and Prognostic Factors of 103 Patients
Gabriella Moroni et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2012)
American College of Rheumatology Guidelines for Screening, Treatment, and Management of Lupus Nephritis
Bevra H. Hahn et al.
ARTHRITIS CARE & RESEARCH (2012)
Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial
Ellen M. Ginzler et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Laquinimod, a once-daily oral drug in development for the treatment of relapsing-remitting multiple sclerosis
Wolfgang Brueck et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2012)
Understanding lupus nephritis: diagnosis, management, and treatment options
Chi Chiu Mok
INTERNATIONAL JOURNAL OF WOMENS HEALTH (2012)
Short-term Outcomes of Induction Therapy With Tacrolimus Versus Cyclophosphamide for Active Lupus Nephritis: A Multicenter Randomized Clinical Trial
Wei Chen et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2011)
Trends in the Incidence, Demographics, and Outcomes of End-Stage Renal Disease Due to Lupus Nephritis in the US From 1995 to 2006
Karen H. Costenbader et al.
ARTHRITIS AND RHEUMATISM (2011)
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
Richard Furie et al.
ARTHRITIS AND RHEUMATISM (2011)
Persistent proteinuria and dyslipidemia increase the risk of progressive chronic kidney disease in lupus erythematosus
Heather N. Reich et al.
KIDNEY INTERNATIONAL (2011)
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Sandra V. Navarra et al.
LANCET (2011)
Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis
Mary Anne Dooley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide
F. A. Houssiau et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial
Frederic A. Houssiau et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Effect of Long-Term Belimumab Treatment on B Cells in Systemic Lupus Erythematosus
Annett M. Jacobi et al.
ARTHRITIS AND RHEUMATISM (2010)
Safety and Efficacy of Rituximab in Systemic Lupus Erythematosus
Benjamin Terrier et al.
ARTHRITIS AND RHEUMATISM (2010)
Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell help
S. Heidt et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomised trials
Luit Penninga et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
Jai Radhakrishnan et al.
KIDNEY INTERNATIONAL (2010)
Pharmacokinetics of mycophenolic acid in severe lupus nephritis
Paungpaga Lertdumrongluk et al.
KIDNEY INTERNATIONAL (2010)
Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study
David Isenberg et al.
RHEUMATOLOGY (2010)
Clinical improvements in proliferative vs membranous lupus nephritis following B-cell depletion: pooled data from two cohorts
Thorunn Jonsdottir et al.
RHEUMATOLOGY (2010)
Systemic lupus erythematosus and its ABCs (APRIL/BLyS complexes)
William Stohl
ARTHRITIS RESEARCH & THERAPY (2010)
Steady-state mycophenolate mofetil pharmacokinetic parameters enable prediction of systemic lupus erythematosus clinical flares: an observational cohort study
Sarah Djabarouti et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Protective Effect of Hydroxychloroquine on Renal Damage in Patients With Lupus Nephritis: LXV, Data From a Multiethnic US Cohort
Guillermo J. Pons-Estel et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Neutrophil Gelatinase-Associated Lipocalin Is a Predictor of the Course of Global and Renal Childhood-Onset Systemic Lupus Erythematosus Disease Activity
Claas H. Hinze et al.
ARTHRITIS AND RHEUMATISM (2009)
The Relationship Between Renal Activity and Quality of Life in Systemic Lupus Erythematosus
Simone Appenzeller et al.
JOURNAL OF RHEUMATOLOGY (2009)
Ethnic Differences in Pediatric Systemic Lupus Erythematosus
Linda T. Hiraki et al.
JOURNAL OF RHEUMATOLOGY (2009)
Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
Gerald B. Appel et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Randomized, Controlled Trial of Prednisone, Cyclophosphamide, and Cyclosporine in Lupus Membranous Nephropathy
Howard A. Austin et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial
Paolo Verdecchia et al.
LANCET (2009)
Rituximab in systemic lupus erythematosus A systematic review of off-label use in 188 cases
M. Ramos-Casals et al.
LUPUS (2009)
Membranous nephropathy in systemic lupus erythematosus: a therapeutic enigma
Chi Chiu Mok
NATURE REVIEWS NEPHROLOGY (2009)
Clinical features and renal outcome in lupus patients with diffuse crescentic glomerulonephritis
Zheng Tang et al.
RHEUMATOLOGY INTERNATIONAL (2009)
Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study
Noa Schwartz et al.
ARTHRITIS RESEARCH & THERAPY (2009)
Successful treatment of class V+IV lupus nephritis with multitarget therapy
Hao Bao et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Risk and predictors of work disability in Chinese patients with systemic lupus erythematosus
C. C. Mok et al.
LUPUS (2008)
Previous antimalarial therapy in patients diagnosed with lupus nephiritis: Influence on outcomes and survival
A. Siso et al.
LUPUS (2008)
The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A
Christian Faul et al.
NATURE MEDICINE (2008)
Effects of mycophenolate mofetil for patients with crescentic lupus nephritis
Zheng Tang et al.
NEPHROLOGY (2008)
Efficacy and safety of tacrolimus compared with ciclosporin A in renal transplantation:: three-year observational results
Bernhard K. Kraemer et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Association between mycophenolic acid 12-h trough levels and clinical endpoints in patients with autoimmune disease on mycophenolate mofetil
Irmgard Neumann et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis
C. -C. Szeto et al.
RHEUMATOLOGY (2008)
Reduced exposure to calcineurin inhibitors in renal transplantation
Henrik Ekberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus:: Data from LUMINA, a multiethnic US cohort (LUMINA L)
Graciela S. Alarcon et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Risk and predictors of arterial thrombosis in lupus and non-lupus primary glomerulonephritis - A comparative study
Chi Chiu Mok et al.
MEDICINE (2007)
A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE
Monica Fernandez et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Severe lupus nephritis: Racial differences in presentation and outcome
Stephen M. Korbet et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years
Gabriella Moroni et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Withdrawal of therapy in patients with proliferative lupus nephritis: long-term follow-up
G Moroni et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide
CC Mok et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus
G. Ruiz-Irastorza et al.
LUPUS (2006)
Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis
EM Ginzler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Incidence and risk factors of thromboembolism in systemic lupus erythematosus - A comparison of three ethnic groups
CC Mok et al.
ARTHRITIS AND RHEUMATISM (2005)
Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: An open-labeled pilot study
CC Mok et al.
KIDNEY INTERNATIONAL (2005)
Sequential therapies for proliferative lupus nephritis
G Contreras et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis
CC Mok et al.
ARTHRITIS AND RHEUMATISM (2004)
Tacrolimus - A further update of its use in the management of organ transplantation
LJ Scott et al.
DRUGS (2003)
Immunosuppressive therapy in lupus nephritis -: The Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide
FA Houssiau et al.
ARTHRITIS AND RHEUMATISM (2002)
Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy - Long-term followup of a cohort of 145 patients participating in randomized controlled studies
GG Illei et al.
ARTHRITIS AND RHEUMATISM (2002)
Cutting edge: Reversal of murine lupus nephritis with CTLA4Ig and cyclophosphamide
DI Daikh et al.
JOURNAL OF IMMUNOLOGY (2001)
Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis
TM Chan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
